Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Current Assets (2021 - 2025)

Historic Current Assets for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $57.1 million.

  • Biote's Current Assets fell 1837.59% to $57.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.1 million, marking a year-over-year decrease of 1837.59%. This contributed to the annual value of $68.1 million for FY2024, which is 4431.48% down from last year.
  • As of Q3 2025, Biote's Current Assets stood at $57.1 million, which was down 1837.59% from $49.5 million recorded in Q2 2025.
  • Biote's 5-year Current Assets high stood at $122.3 million for Q4 2023, and its period low was $365674.0 during Q1 2022.
  • In the last 5 years, Biote's Current Assets had a median value of $68.7 million in 2025 and averaged $68.8 million.
  • Per our database at Business Quant, Biote's Current Assets plummeted by 7562.39% in 2022 and then soared by 2928573.7% in 2023.
  • Quarter analysis of 5 years shows Biote's Current Assets stood at $47.1 million in 2021, then skyrocketed by 114.88% to $101.2 million in 2022, then rose by 20.92% to $122.3 million in 2023, then plummeted by 44.31% to $68.1 million in 2024, then fell by 16.15% to $57.1 million in 2025.
  • Its Current Assets stands at $57.1 million for Q3 2025, versus $49.5 million for Q2 2025 and $68.7 million for Q1 2025.